Skip Nav Destination
Issues
May 2016
ISSN 2296-5270
EISSN 2296-5262
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2016, Vol. 39, No. 5
Editorial Board / Contents / Imprint
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 253–256.
https://doi.org/10.1159/000446228
Editorial
Challenging Results Make Us Think
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 258–259.
https://doi.org/10.1159/000446163
Original Article
Use of Complementary and Alternative Medicine in Cancer Patients: A Prospective Questionnaire-Based Study in an Oncological Outpatient Clinic
Subject Area:
Oncology
Julia König; Kristina Geschwill; Andreas Lang; Felix K. Tauchert; Ralf-Dieter Hofheinz; Melanie Kripp
Oncol Res Treat (2016) 39 (5): 260–265.
https://doi.org/10.1159/000446008
C-Reactive Protein is a Prognostic Marker for Patients with Castration-Resistant Prostate Cancer
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 266–271.
https://doi.org/10.1159/000446098
Internet Information for Patients on Cancer Diets - an Analysis of German Websites
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 273–281.
https://doi.org/10.1159/000445861
Diagnostic Impacts of Serum CA-125 Levels, Pap Smear Evaluation, and Endometrial Sampling in Women with Endometrial Clear Cell Carcinoma
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 283–288.
https://doi.org/10.1159/000445860
Novel Insights from Clinical Practice
Advances in Image-Guided Radiation Therapy for Primary Cardiac Angiosarcoma: The Role of PET-CT and MRI
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 290–294.
https://doi.org/10.1159/000445864
Review Article
Targeted Therapy in HER2-Positive Breast Cancer
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 295–302.
https://doi.org/10.1159/000446038
Reports of Oncological Societies
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 303–305.
https://doi.org/10.1159/000446204
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 307.
https://doi.org/10.1159/000446229
PharmaForum
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 308–309.
https://doi.org/10.1159/000446230
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 310–313.
https://doi.org/10.1159/000446231
Meetings and Conferences
Subject Area:
Oncology
Oncol Res Treat (2016) 39 (5): 315–316.
https://doi.org/10.1159/000446205
